CEO interview with Trading Direkt Healthcare

Richard Godfrey, CEO, comments on the top-line results of the Phase IIb trial of mesdopetam in PD-LIDs in Trading Direkt Healthcare. The show was live-streamed on Monday, January 23, 2023.